ArticleJournal of gynecologic oncology2023

Lymphocyte activation gene (LAG)-3 is a potential immunotherapeutic target for microsatellite stable, programmed death-ligand 1 (PD-L1)-positive endometrioid endometrial cancer.

Jin Hwa Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.